Efficacy of maternal tenofovir disoproxil fumarate in interrupting mother-to-infant transmission of hepatitis B virus. - Wikidata - wikimedia - TriplyDB

Efficacy of maternal tenofovir disoproxil fumarate in interrupting mother-to-infant transmission of hepatitis B virus.

Efficacy of maternal tenofovir disoproxil fumarate in interrupting mother-to-infant transmission of hepatitis B virus.

http://www.wikidata.org/entity/Q41349327

about

Approved Antiviral Drugs over the Past 50 Years Hepatitis B Management in the Pregnant Patient: An Update Asian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update.A Review of Antiviral Use for the Treatment of Chronic Hepatitis B Virus Infection in Pregnant Women.Efficacy and safety of tenofovir disoproxil fumarate in preventing vertical transmission of hepatitis B in pregnancies with high viral load.Antiviral therapy in chronic hepatitis B viral infection during pregnancy: A systematic review and meta-analysis.A Survey Study of Pregnant Women and Healthcare Practitioners Assessing the Knowledge of Attitudes and Practices of Hepatitis B Management at a Teaching Hospital in Kumasi, Ghana, West Africa.Elimination of Hepatitis B: Is It a Mission Possible?PrEP as Peri-conception HIV Prevention for Women and Men.Telbivudine therapy for chronic hepatitis B: A journey to identify super-responders and to optimize treatment using the roadmap model.Hepatitis B: 50 years after the discovery of Australia antigen.Managing HBV in pregnancy. Prevention, prophylaxis, treatment and follow-up: position paper produced by Australian, UK and New Zealand key opinion leaders.A review of strategies to prevent mother-to-infant transmission of hepatitis B virus infection.Low HIV incidence in pregnant and postpartum women receiving a community-based combination HIV prevention intervention in a high HIV incidence setting in South Africa.Pediatric liver diseases: current challenges and future perspectives.HBV: Do I treat my immunotolerant patients?Chronic HBV: which pregnant women should be treated?DNA polymerase inhibitors for treating hepatitis B: a safety evaluation.Safety of oral tenofovir disoproxil fumarate-based HIV pre-exposure prophylaxis use in lactating HIV-uninfected women.Systematic review with meta-analysis: the risk of mother-to-child transmission of hepatitis B virus infection in sub-Saharan Africa.Hepatitis A to E: what's new?Systematic review with meta-analysis: the efficacy and safety of tenofovir to prevent mother-to-child transmission of hepatitis B virus.Quantitative maternal hepatitis B surface antigen predicts maternally transmitted hepatitis B virus infection.Antiretroviral therapy for pregnant women living with HIV or hepatitis B: a systematic review and meta-analysis.Efficacy of long-term tenofovir-based rescue therapy in patients with chronic hepatitis B refractory to nucleoside/nucleotide analogs.Serum Alanine Aminotransferase and Hepatitis B DNA Flares in Pregnant and Postpartum Women with Chronic Hepatitis B.Cost-effectiveness of quantitative hepatitis B virus surface antigen testing in pregnancy in predicting vertical transmission risk.Nucleoside/nucleotide analogues in the treatment of chronic hepatitis B infection during pregnancy: a systematic review.HBV Core Protein Enhances Cytokine Production.Third-trimester tenofovir to prevent mother-to-child hepatitis B virus transmission.Antiviral therapy for hepatitis B virus during second pregnancies.Safety and efficacy of telbivudine in late pregnancy to prevent mother-to-child transmission of hepatitis B virus: a multicenter prospective cohort study.Mother-to-infant transmission of hepatitis B virus: challenges and perspectives.Management of chronic hepatitis B patients in immunetolerant phase: what latest guidelines recommend.Management of Pregnant Women and Children: Focusing on Preventing Mother-to-Infant Transmission.Update on Prevention, Diagnosis, and Treatment and of Chronic Hepatitis B: AASLD 2018 Hepatitis B Guidance.INASL Position Statements on Prevention, Diagnosis and Management of Hepatitis B Virus Infection in India: The Andaman Statements.Tenofovir versus Placebo to Prevent Perinatal Transmission of Hepatitis B.Prevention of mother-to-child transmission of hepatitis B virus: a phase III, placebo-controlled, double-blind, randomized clinical trial to assess the efficacy and safety of a short course of tenofovir disoproxil fumarate in women with hepatitis B v Current evidence on the management of hepatitis B in pregnancy

P2860

Q27755387-F2E1B5C0-5977-48CF-BC71-32458E3EDF53 Q28066219-E98D0F22-1301-4BA9-ADDB-B9F1DB92B3AE Q30391932-AADEA8D8-2D2B-4C31-838A-D40875F2706D Q33711399-54F38BD1-D638-42E7-AB91-ED5AC1C14A82 Q33829957-D7119837-106C-486F-8F98-500591B2A2AC Q35840548-EC44261D-7ED3-4A26-A2D6-526FDD163B65 Q36262587-A70DC43A-5BF2-4B74-BEAD-B8640AB57B7E Q36307834-5A22872C-E3E8-4461-A18A-E099153849A6 Q36963511-30AD61DA-2F20-4289-9A54-D81E77E52550 Q38559455-3280AF40-4810-4647-854D-252AA5C14E11 Q38568256-34D78712-8BDF-4F26-8973-9E18D8DFD3FE Q38609568-166C7B95-9406-4DBB-8A27-B9E97AD24513 Q38632945-8B0C2AFF-4057-444B-98AD-55EF12D3CC5D Q38657474-08270A8F-2FF2-4057-AA79-8DA569B02697 Q38660846-6423B7BA-5C4D-40D7-8305-9C930C0184C4 Q38685592-B869519B-A2A6-46B1-8309-5BDB41F78C90 Q38685599-14511363-2423-4D22-A13F-75E1E5419C0A Q38692333-1B56D1BB-9C99-4CD4-82D3-DAB7D97F5BB2 Q38750453-938B0A32-A7D5-4E4F-BF99-E2D36D8FFF21 Q38954793-5659FA74-ADD5-46F7-878D-4A40E4BC99DD Q39237214-780AD552-130A-496B-94D5-488713844618 Q39258357-E9CC94C8-DC71-40CC-A242-F95F74840A9D Q39864436-2DBEC43F-2673-42F1-AE67-CCACE55C73D6 Q40046821-E9FDCF04-019C-4E98-A933-F8C318D022B2 Q40555175-EE7A0226-B4DC-4D05-BCC0-349D7221627B Q40600289-4814E0C5-83C9-48EE-B040-4DB55766323D Q40722693-9674BE9B-4F88-4166-8BCE-E9C5EA0E79D3 Q41918890-64B9E047-ED59-42D7-BC5D-E8A4F9F1A2B1 Q42121965-B8B4136B-0BAF-4A6A-8369-1615566D2C0C Q45073764-330ED25E-C13D-4B28-8446-6D059A3EF2F0 Q45323532-BF3173C4-5045-426F-A3B8-1F5B7964FCCA Q45323953-E196D85F-F4F7-414B-98EB-DB6D842789D8 Q45325793-B3D6DDEB-5676-4B13-A328-37681833A2F6 Q47550875-D6ADFDCA-F28F-47BE-B426-BC8C6CE050B7 Q47575321-888412F0-8243-482F-AFF2-F4A4175CEF2E Q50190669-C4743FE3-A4D5-4C56-9D37-DF1B3A979EBD Q54216584-D53106AC-D4DE-47FD-8D06-728F5F0665EB Q54260607-3EBA6775-B7AB-4D9D-B155-2D89D218CD76 Q56839003-BAAB10F9-82BD-4E04-BCE4-F16C5256509B Q57491228-E8B04DA2-2A42-4F2B-9948-3899DBF0D7A0

P2860

Efficacy of maternal tenofovir disoproxil fumarate in interrupting mother-to-infant transmission of hepatitis B virus.

http://www.wikidata.org/entity/Q41349327

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Efficacy of maternal tenofovir ...... smission of hepatitis B virus.

@en

type

label

Efficacy of maternal tenofovir ...... smission of hepatitis B virus.

@en

prefLabel

Efficacy of maternal tenofovir ...... smission of hepatitis B virus.

@en

P1433

Q41349327-7DDB28E2-C56F-4EB4-BE98-21C635D5FB1C

P1476

Q41349327-0F0AC53B-C8A1-45E0-973D-660F7680A250

P2093

Q41349327-0B264931-84AA-40D1-AB16-5B766F1276DC

Q41349327-16AA4AF1-D7B4-44A3-843C-AC449F21140F

Q41349327-1C9E193E-AA6D-4048-AE69-7A7497E628A6

Q41349327-1EFEA52E-3149-4835-A40D-BA54AA025C30

Q41349327-27EC80B3-1EA8-4845-BFB9-A32D1CEF9E00

Q41349327-3584E68B-A910-47C6-AB5F-FFC6BC2BFB93

Q41349327-3A169ED4-A837-4C45-B3FD-C8327671A3E0

Q41349327-476BD9B0-CCD3-423F-8FA6-9F4ECC43ED97

Q41349327-5FB0DD69-3B74-4255-A659-D437EE624A1F

Q41349327-83DAB062-36EB-4BC0-A4EC-8F1DE7B76D90

P2860

Q41349327-06FA36C3-A90C-4E84-9D29-85A8EC985626

Q41349327-0DFFBA75-A0F8-46A7-A089-C10A7771CF28

Q41349327-1A453EB5-B7D0-4ABC-8571-40AF0B5721BB

Q41349327-2048892B-3AF8-40B2-9504-43E40F26491A

Q41349327-227AB2FC-41A8-42F4-8B23-3B358D75D9C1

Q41349327-2BFFAD72-E6B3-40E8-9957-94CA051D7F9A

Q41349327-385AAB7A-839D-4424-B32D-26599A70E24F

Q41349327-461D83B8-3475-4066-89F5-A75921D1E104

Q41349327-46AE38BF-9593-4CB4-B87C-D81951329AD5

Q41349327-56670D0C-92A9-46B3-8F1B-048BA3447571

P304

Q41349327-46DD06C1-8BC2-4AD9-82F3-B6955CFE1D3A

P31

Q41349327-5B6644B7-A6FD-48CC-96BB-6E17FA3B9B63

P356

Q41349327-0517D813-699B-4161-AD9A-24B9A773A048

P407

Q41349327-5BB582C8-4A30-4DE4-B91B-96BCAC0C7A99

P433

Q41349327-8313AFDB-A3A3-45F0-9BF8-39D9D62AA4B0

P478

Q41349327-E9E01B45-9DC5-43A2-B598-FD8BD881E621

P50

Q41349327-60A7C345-CAFB-45D0-B310-4A9B8F8578FD

Q41349327-6B7FC685-4751-4C9B-B4AB-F64DC00002A0

Q41349327-9E647DDD-D209-43C0-98BC-F6AF284EEE74

Q41349327-B6169806-933A-42DA-B474-3D4115C42AFA

P577

Q41349327-54852DCF-84D4-4CF8-8D5A-54EACAD08AC9

P698

Q41349327-5BB41E07-C012-431C-9752-78E46044163E

P356

P1433

P1476

Efficacy of maternal tenofovir ...... smission of hepatitis B virus.

@en

P2093

Chin-Hao Chang

http://www.w3.org/2001/XMLSchema#string

Chyi-Long Lee

http://www.w3.org/2001/XMLSchema#string

Hans Hsienhong Lin

http://www.w3.org/2001/XMLSchema#string

Hsien-Ming Lin

http://www.w3.org/2001/XMLSchema#string

Huey-Ling Chen

http://www.w3.org/2001/XMLSchema#string

Jen-Jan Hu

http://www.w3.org/2001/XMLSchema#string

Jenn-Jeih Hsu

http://www.w3.org/2001/XMLSchema#string

K Arnold Chan

http://www.w3.org/2001/XMLSchema#string

Lu-Lu Zhao

http://www.w3.org/2001/XMLSchema#string

Mei-Hwei Chang

http://www.w3.org/2001/XMLSchema#string

P2860

Prevention of vertical transmission of hepatitis B: an observational study.

Telbivudine or lamivudine use in late pregnancy safely reduces perinatal transmission of hepatitis B virus in real-life practice.

Hepatitis B and pregnancy: an underestimated issue.

Efficacy and safety of tenofovir disoproxil fumarate in pregnancy for the prevention of vertical transmission of HBV infection.

Antiviral therapy for chronic hepatitis B in pregnancy.

Efficacy of hepatitis B vaccine in the Gambian expanded programme on immunisation.

Two decades of universal hepatitis B vaccination in taiwan: impact and implication for future strategies.

Association of HLA alleles with the responsiveness to hepatitis B virus vaccination in Korean infants.

Comparison of telbivudine versus lamivudine in interrupting perinatal transmission of hepatitis B virus.

Efficacy and safety of tenofovir disoproxil fumarate in pregnancy to prevent perinatal transmission of hepatitis B virus.

P304

375-386

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/HEP.27837

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

62

http://www.w3.org/2001/XMLSchema#string

P50

Ming-Kwang Shyu

Ding-Shinn Chen

P577

2015-04-07T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25851052

http://www.w3.org/2001/XMLSchema#string